MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.gore.2019.02.004

Медицинская библиотека · Gynecologic oncology reports · 2019

Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment.

Muratori L, Gorzegno G, Sperone P, Andreozzi A, Di Maio M, Scagliotti G V

Клинический случайСтатьяПеревод в очереди

Аннотация

BACKGROUND

Luteinized thecoma with sclerosing peritonitis (LTSP) is a very rare condition, and its clinical management is not evidence-based. Here we describe a case of long-term disease control achieved with leuprorelin and tamoxifen therapy.

CASE PRESENTATION: A 18-year-old woman with acute abdomen underwent surgical removal of an ovarian mass and received diagnosis of LTSP. Treatment plan consisted of leuprorelin and tamoxifen, followed by a good instrumental response. After 5 years, leuprorelin was stopped, and the patient continued tamoxifen alone. Ten years after diagnosis, she is still disease free.

CONCLUSION

Even in the absence of solid evidence, the combination of leuprorelin and tamoxifen could be considered as a possible medical treatment of LTSP. Considering the limitations related to the rarity of disease, further studies are needed to improve its management.

Для цитирования: Muratori L, Gorzegno G, Sperone P, Andreozzi A, Di Maio M, Scagliotti G V. Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment.. Gynecologic oncology reports. 2019. DOI: 10.1016/j.gore.2019.02.004.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.